HEADER HYDROLASE 12-MAR-04 1VCU TITLE STRUCTURE OF THE HUMAN CYTOSOLIC SIALIDASE NEU2 IN COMPLEX WITH THE TITLE 2 INHIBITOR DANA COMPND MOL_ID: 1; COMPND 2 MOLECULE: SIALIDASE 2; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: NEU2, CYTOSOLIC SIALIDASE, N-ACETYL-ALPHA- NEURAMINIDASE 2; COMPND 5 EC: 3.2.1.18; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PGEX-2T KEYWDS SIALIDASE, NEURAMINIDASE, GANGLIOSIDE, DANA, SIALIC ACID, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR L.M.G.CHAVAS,P.FUSI,C.TRINGALI,B.VENERANDO,G.TETTAMANTI,R.KATO, AUTHOR 2 E.MONTI,S.WAKATSUKI REVDAT 5 25-OCT-23 1VCU 1 HETSYN REVDAT 4 29-JUL-20 1VCU 1 REMARK SEQADV SITE REVDAT 3 24-FEB-09 1VCU 1 VERSN REVDAT 2 18-JAN-05 1VCU 1 JRNL REVDAT 1 02-NOV-04 1VCU 0 JRNL AUTH L.M.G.CHAVAS,C.TRINGALI,P.FUSI,B.VENERANDO,G.TETTAMANTI, JRNL AUTH 2 R.KATO,E.MONTI,S.WAKATSUKI JRNL TITL CRYSTAL STRUCTURE OF THE HUMAN CYTOSOLIC SIALIDASE NEU2: JRNL TITL 2 EVIDENCE FOR THE DYNAMIC NATURE OF SUBSTRATE RECOGNITION JRNL REF J.BIOL.CHEM. V. 280 469 2005 JRNL REFN ISSN 0021-9258 JRNL PMID 15501818 JRNL DOI 10.1074/JBC.M411506200 REMARK 2 REMARK 2 RESOLUTION. 2.85 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.85 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 20807 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.195 REMARK 3 FREE R VALUE : 0.266 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 1050 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5850 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 100 REMARK 3 SOLVENT ATOMS : 131 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 1.396 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1VCU COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 17-MAR-04. REMARK 100 THE DEPOSITION ID IS D_1000006472. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 27-JUN-03 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : PHOTON FACTORY REMARK 200 BEAMLINE : BL-6A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9700 REMARK 200 MONOCHROMATOR : SI(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUAMTUM 4R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 20807 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.850 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.11500 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 11.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.85 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.95 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.6 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.31300 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 1SNT REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.12 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.64 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 2-DEOXY-2,3-DEHYDRO-N-ACETYL REMARK 280 NEURAMINIC ACID, 2-METHYL-2,4-PENTANEDIOL, GUANIDINE REMARK 280 HYDROCHLORIDE, PH 7.0, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 289K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 78.82500 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 37.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 78.82500 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 37.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A -1 REMARK 465 SER A 0 REMARK 465 THR A 226 REMARK 465 GLY A 227 REMARK 465 GLU A 228 REMARK 465 SER A 284 REMARK 465 GLY A 285 REMARK 465 PRO A 286 REMARK 465 GLY A 287 REMARK 465 LEU A 378 REMARK 465 PRO A 379 REMARK 465 GLN A 380 REMARK 465 GLY B -1 REMARK 465 SER B 0 REMARK 465 SER B 284 REMARK 465 GLY B 285 REMARK 465 PRO B 286 REMARK 465 GLY B 287 REMARK 465 LEU B 378 REMARK 465 PRO B 379 REMARK 465 GLN B 380 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO A 268 C - N - CA ANGL. DEV. = 10.8 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ILE A 22 77.13 55.93 REMARK 500 GLU A 50 -64.14 -139.77 REMARK 500 ALA A 75 -33.84 -33.70 REMARK 500 ALA A 77 77.08 -66.34 REMARK 500 ARG A 78 145.68 175.57 REMARK 500 ASN A 86 60.95 67.32 REMARK 500 ASP A 131 44.00 -148.96 REMARK 500 CYS A 164 -161.87 -101.49 REMARK 500 ASN A 168 41.45 -101.89 REMARK 500 ARG A 172 85.72 41.69 REMARK 500 ALA A 178 -172.78 -174.00 REMARK 500 VAL A 212 -166.10 -117.73 REMARK 500 GLN A 214 153.71 -33.87 REMARK 500 LEU A 217 -144.90 -108.37 REMARK 500 LEU A 240 -157.18 -70.85 REMARK 500 PRO A 268 -62.90 -28.89 REMARK 500 PRO A 269 -92.87 -44.16 REMARK 500 ASP A 306 67.22 66.37 REMARK 500 SER A 331 106.68 -35.06 REMARK 500 ALA A 333 -121.87 -128.84 REMARK 500 ASN A 357 86.59 43.09 REMARK 500 ASP A 358 48.69 36.46 REMARK 500 VAL B 6 -151.98 -100.12 REMARK 500 ILE B 22 65.49 63.02 REMARK 500 GLU B 50 -85.64 -116.79 REMARK 500 ALA B 77 74.51 -64.12 REMARK 500 ASN B 86 65.51 67.80 REMARK 500 CYS B 164 -158.71 -97.12 REMARK 500 ILE B 187 -60.62 -101.53 REMARK 500 VAL B 212 -156.19 -93.20 REMARK 500 LEU B 217 -135.38 -109.68 REMARK 500 GLN B 256 -75.50 -120.15 REMARK 500 GLU B 257 0.21 -45.23 REMARK 500 SER B 258 127.64 -32.46 REMARK 500 HIS B 297 149.59 179.65 REMARK 500 ASP B 306 70.09 63.25 REMARK 500 ALA B 317 104.33 -31.81 REMARK 500 ALA B 333 -124.69 -129.52 REMARK 500 GLU B 361 146.59 -178.86 REMARK 500 GLU B 376 -85.08 -68.47 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1SNT RELATED DB: PDB REMARK 900 HUMAN NEU2 APO-FORM REMARK 900 RELATED ID: 1SO7 RELATED DB: PDB REMARK 900 THE SAME PROTEIN, SUGAR-INDUCED FORM DBREF 1VCU A 1 380 UNP Q9Y3R4 NEUR2_HUMAN 1 380 DBREF 1VCU B 1 380 UNP Q9Y3R4 NEUR2_HUMAN 1 380 SEQADV 1VCU GLY A -1 UNP Q9Y3R4 CLONING ARTIFACT SEQADV 1VCU SER A 0 UNP Q9Y3R4 CLONING ARTIFACT SEQADV 1VCU GLY B -1 UNP Q9Y3R4 CLONING ARTIFACT SEQADV 1VCU SER B 0 UNP Q9Y3R4 CLONING ARTIFACT SEQRES 1 A 382 GLY SER MET ALA SER LEU PRO VAL LEU GLN LYS GLU SER SEQRES 2 A 382 VAL PHE GLN SER GLY ALA HIS ALA TYR ARG ILE PRO ALA SEQRES 3 A 382 LEU LEU TYR LEU PRO GLY GLN GLN SER LEU LEU ALA PHE SEQRES 4 A 382 ALA GLU GLN ARG ALA SER LYS LYS ASP GLU HIS ALA GLU SEQRES 5 A 382 LEU ILE VAL LEU ARG ARG GLY ASP TYR ASP ALA PRO THR SEQRES 6 A 382 HIS GLN VAL GLN TRP GLN ALA GLN GLU VAL VAL ALA GLN SEQRES 7 A 382 ALA ARG LEU ASP GLY HIS ARG SER MET ASN PRO CYS PRO SEQRES 8 A 382 LEU TYR ASP ALA GLN THR GLY THR LEU PHE LEU PHE PHE SEQRES 9 A 382 ILE ALA ILE PRO GLY GLN VAL THR GLU GLN GLN GLN LEU SEQRES 10 A 382 GLN THR ARG ALA ASN VAL THR ARG LEU CYS GLN VAL THR SEQRES 11 A 382 SER THR ASP HIS GLY ARG THR TRP SER SER PRO ARG ASP SEQRES 12 A 382 LEU THR ASP ALA ALA ILE GLY PRO ALA TYR ARG GLU TRP SEQRES 13 A 382 SER THR PHE ALA VAL GLY PRO GLY HIS CYS LEU GLN LEU SEQRES 14 A 382 ASN ASP ARG ALA ARG SER LEU VAL VAL PRO ALA TYR ALA SEQRES 15 A 382 TYR ARG LYS LEU HIS PRO ILE GLN ARG PRO ILE PRO SER SEQRES 16 A 382 ALA PHE CYS PHE LEU SER HIS ASP HIS GLY ARG THR TRP SEQRES 17 A 382 ALA ARG GLY HIS PHE VAL ALA GLN ASP THR LEU GLU CYS SEQRES 18 A 382 GLN VAL ALA GLU VAL GLU THR GLY GLU GLN ARG VAL VAL SEQRES 19 A 382 THR LEU ASN ALA ARG SER HIS LEU ARG ALA ARG VAL GLN SEQRES 20 A 382 ALA GLN SER THR ASN ASP GLY LEU ASP PHE GLN GLU SER SEQRES 21 A 382 GLN LEU VAL LYS LYS LEU VAL GLU PRO PRO PRO GLN GLY SEQRES 22 A 382 CYS GLN GLY SER VAL ILE SER PHE PRO SER PRO ARG SER SEQRES 23 A 382 GLY PRO GLY SER PRO ALA GLN TRP LEU LEU TYR THR HIS SEQRES 24 A 382 PRO THR HIS SER TRP GLN ARG ALA ASP LEU GLY ALA TYR SEQRES 25 A 382 LEU ASN PRO ARG PRO PRO ALA PRO GLU ALA TRP SER GLU SEQRES 26 A 382 PRO VAL LEU LEU ALA LYS GLY SER CYS ALA TYR SER ASP SEQRES 27 A 382 LEU GLN SER MET GLY THR GLY PRO ASP GLY SER PRO LEU SEQRES 28 A 382 PHE GLY CYS LEU TYR GLU ALA ASN ASP TYR GLU GLU ILE SEQRES 29 A 382 VAL PHE LEU MET PHE THR LEU LYS GLN ALA PHE PRO ALA SEQRES 30 A 382 GLU TYR LEU PRO GLN SEQRES 1 B 382 GLY SER MET ALA SER LEU PRO VAL LEU GLN LYS GLU SER SEQRES 2 B 382 VAL PHE GLN SER GLY ALA HIS ALA TYR ARG ILE PRO ALA SEQRES 3 B 382 LEU LEU TYR LEU PRO GLY GLN GLN SER LEU LEU ALA PHE SEQRES 4 B 382 ALA GLU GLN ARG ALA SER LYS LYS ASP GLU HIS ALA GLU SEQRES 5 B 382 LEU ILE VAL LEU ARG ARG GLY ASP TYR ASP ALA PRO THR SEQRES 6 B 382 HIS GLN VAL GLN TRP GLN ALA GLN GLU VAL VAL ALA GLN SEQRES 7 B 382 ALA ARG LEU ASP GLY HIS ARG SER MET ASN PRO CYS PRO SEQRES 8 B 382 LEU TYR ASP ALA GLN THR GLY THR LEU PHE LEU PHE PHE SEQRES 9 B 382 ILE ALA ILE PRO GLY GLN VAL THR GLU GLN GLN GLN LEU SEQRES 10 B 382 GLN THR ARG ALA ASN VAL THR ARG LEU CYS GLN VAL THR SEQRES 11 B 382 SER THR ASP HIS GLY ARG THR TRP SER SER PRO ARG ASP SEQRES 12 B 382 LEU THR ASP ALA ALA ILE GLY PRO ALA TYR ARG GLU TRP SEQRES 13 B 382 SER THR PHE ALA VAL GLY PRO GLY HIS CYS LEU GLN LEU SEQRES 14 B 382 ASN ASP ARG ALA ARG SER LEU VAL VAL PRO ALA TYR ALA SEQRES 15 B 382 TYR ARG LYS LEU HIS PRO ILE GLN ARG PRO ILE PRO SER SEQRES 16 B 382 ALA PHE CYS PHE LEU SER HIS ASP HIS GLY ARG THR TRP SEQRES 17 B 382 ALA ARG GLY HIS PHE VAL ALA GLN ASP THR LEU GLU CYS SEQRES 18 B 382 GLN VAL ALA GLU VAL GLU THR GLY GLU GLN ARG VAL VAL SEQRES 19 B 382 THR LEU ASN ALA ARG SER HIS LEU ARG ALA ARG VAL GLN SEQRES 20 B 382 ALA GLN SER THR ASN ASP GLY LEU ASP PHE GLN GLU SER SEQRES 21 B 382 GLN LEU VAL LYS LYS LEU VAL GLU PRO PRO PRO GLN GLY SEQRES 22 B 382 CYS GLN GLY SER VAL ILE SER PHE PRO SER PRO ARG SER SEQRES 23 B 382 GLY PRO GLY SER PRO ALA GLN TRP LEU LEU TYR THR HIS SEQRES 24 B 382 PRO THR HIS SER TRP GLN ARG ALA ASP LEU GLY ALA TYR SEQRES 25 B 382 LEU ASN PRO ARG PRO PRO ALA PRO GLU ALA TRP SER GLU SEQRES 26 B 382 PRO VAL LEU LEU ALA LYS GLY SER CYS ALA TYR SER ASP SEQRES 27 B 382 LEU GLN SER MET GLY THR GLY PRO ASP GLY SER PRO LEU SEQRES 28 B 382 PHE GLY CYS LEU TYR GLU ALA ASN ASP TYR GLU GLU ILE SEQRES 29 B 382 VAL PHE LEU MET PHE THR LEU LYS GLN ALA PHE PRO ALA SEQRES 30 B 382 GLU TYR LEU PRO GLN HET DAN A 381 20 HET EPE A 382 15 HET EPE A 383 15 HET DAN B 381 20 HET EPE B 382 15 HET EPE B 383 15 HETNAM DAN 2-DEOXY-2,3-DEHYDRO-N-ACETYL-NEURAMINIC ACID HETNAM EPE 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID HETSYN DAN NEU5AC2EN HETSYN EPE HEPES FORMUL 3 DAN 2(C11 H17 N O8) FORMUL 4 EPE 4(C8 H18 N2 O4 S) FORMUL 9 HOH *131(H2 O) HELIX 1 1 LYS A 45 ALA A 49 5 5 HELIX 2 2 THR A 110 ARG A 118 1 9 HELIX 3 3 LEU A 142 ILE A 147 1 6 HELIX 4 4 GLY A 148 ARG A 152 5 5 HELIX 5 5 ALA A 317 TRP A 321 5 5 HELIX 6 6 LEU A 369 PHE A 373 1 5 HELIX 7 7 PRO A 374 TYR A 377 5 4 HELIX 8 8 LYS B 45 GLU B 47 5 3 HELIX 9 9 THR B 110 THR B 117 1 8 HELIX 10 10 LEU B 142 ILE B 147 1 6 HELIX 11 11 GLY B 148 ARG B 152 5 5 HELIX 12 12 ALA B 317 TRP B 321 5 5 HELIX 13 13 LEU B 369 PHE B 373 1 5 SHEET 1 A 4 GLN A 8 GLN A 14 0 SHEET 2 A 4 GLU A 361 THR A 368 -1 O PHE A 364 N GLU A 10 SHEET 3 A 4 PRO A 348 ALA A 356 -1 N CYS A 352 O LEU A 365 SHEET 4 A 4 CYS A 332 THR A 342 -1 N GLY A 341 O LEU A 349 SHEET 1 B 4 ALA A 19 LEU A 28 0 SHEET 2 B 4 SER A 33 ARG A 41 -1 O GLU A 39 N ARG A 21 SHEET 3 B 4 LEU A 51 ASP A 60 -1 O GLY A 57 N LEU A 34 SHEET 4 B 4 GLN A 65 TRP A 68 -1 O GLN A 65 N ASP A 60 SHEET 1 C 4 ALA A 19 LEU A 28 0 SHEET 2 C 4 SER A 33 ARG A 41 -1 O GLU A 39 N ARG A 21 SHEET 3 C 4 LEU A 51 ASP A 60 -1 O GLY A 57 N LEU A 34 SHEET 4 C 4 GLU A 72 VAL A 73 -1 O GLU A 72 N LEU A 54 SHEET 1 D 3 HIS A 82 ASP A 92 0 SHEET 2 D 3 THR A 97 PRO A 106 -1 O PHE A 99 N LEU A 90 SHEET 3 D 3 ARG A 123 SER A 129 -1 O SER A 129 N LEU A 98 SHEET 1 E 3 TRP A 154 VAL A 159 0 SHEET 2 E 3 LEU A 174 ARG A 182 -1 O TYR A 181 N SER A 155 SHEET 3 E 3 LEU A 165 GLN A 166 -1 N LEU A 165 O VAL A 175 SHEET 1 F 4 TRP A 154 VAL A 159 0 SHEET 2 F 4 LEU A 174 ARG A 182 -1 O TYR A 181 N SER A 155 SHEET 3 F 4 ILE A 191 SER A 199 -1 O PHE A 197 N VAL A 176 SHEET 4 F 4 ALA A 207 ARG A 208 -1 O ALA A 207 N LEU A 198 SHEET 1 G 4 CYS A 219 VAL A 224 0 SHEET 2 G 4 VAL A 231 ALA A 236 -1 O VAL A 231 N VAL A 224 SHEET 3 G 4 ALA A 242 SER A 248 -1 O VAL A 244 N ALA A 236 SHEET 4 G 4 GLU A 257 VAL A 265 -1 O LEU A 264 N ARG A 243 SHEET 1 H 4 SER A 275 PRO A 280 0 SHEET 2 H 4 GLN A 291 PRO A 298 -1 O TRP A 292 N PHE A 279 SHEET 3 H 4 LEU A 307 ASN A 312 -1 O TYR A 310 N TYR A 295 SHEET 4 H 4 VAL A 325 LEU A 326 -1 O VAL A 325 N ALA A 309 SHEET 1 I 7 GLN B 8 GLN B 14 0 SHEET 2 I 7 GLU B 361 THR B 368 -1 O PHE B 364 N GLU B 10 SHEET 3 I 7 PRO B 348 ALA B 356 -1 N CYS B 352 O LEU B 365 SHEET 4 I 7 VAL B 325 THR B 342 -1 N MET B 340 O LEU B 349 SHEET 5 I 7 ALA B 305 ASN B 312 -1 N LEU B 307 O LEU B 327 SHEET 6 I 7 GLN B 291 PRO B 298 -1 N TYR B 295 O TYR B 310 SHEET 7 I 7 SER B 275 PRO B 280 -1 N SER B 275 O THR B 296 SHEET 1 J 4 ALA B 19 LEU B 28 0 SHEET 2 J 4 SER B 33 ARG B 41 -1 O GLU B 39 N ARG B 21 SHEET 3 J 4 ALA B 49 ASP B 60 -1 O GLY B 57 N LEU B 34 SHEET 4 J 4 GLN B 65 TRP B 68 -1 O GLN B 65 N ASP B 60 SHEET 1 K 4 ALA B 19 LEU B 28 0 SHEET 2 K 4 SER B 33 ARG B 41 -1 O GLU B 39 N ARG B 21 SHEET 3 K 4 ALA B 49 ASP B 60 -1 O GLY B 57 N LEU B 34 SHEET 4 K 4 GLU B 72 VAL B 73 -1 O GLU B 72 N LEU B 54 SHEET 1 L 4 HIS B 82 TYR B 91 0 SHEET 2 L 4 LEU B 98 PRO B 106 -1 O PHE B 99 N LEU B 90 SHEET 3 L 4 ARG B 123 SER B 129 -1 O ARG B 123 N ALA B 104 SHEET 4 L 4 ARG B 140 ASP B 141 -1 O ARG B 140 N GLN B 126 SHEET 1 M 3 TRP B 154 VAL B 159 0 SHEET 2 M 3 LEU B 174 ARG B 182 -1 O TYR B 181 N SER B 155 SHEET 3 M 3 LEU B 165 GLN B 166 -1 N LEU B 165 O VAL B 175 SHEET 1 N 4 TRP B 154 VAL B 159 0 SHEET 2 N 4 LEU B 174 ARG B 182 -1 O TYR B 181 N SER B 155 SHEET 3 N 4 ILE B 191 SER B 199 -1 O PHE B 195 N ALA B 178 SHEET 4 N 4 ALA B 207 ARG B 208 -1 O ALA B 207 N LEU B 198 SHEET 1 O 4 CYS B 219 THR B 226 0 SHEET 2 O 4 GLN B 229 ALA B 236 -1 O GLN B 229 N THR B 226 SHEET 3 O 4 ALA B 242 SER B 248 -1 O VAL B 244 N ALA B 236 SHEET 4 O 4 GLN B 259 VAL B 265 -1 O GLN B 259 N GLN B 245 CISPEP 1 GLY A 160 PRO A 161 0 -0.01 CISPEP 2 PRO A 315 PRO A 316 0 -0.02 CISPEP 3 GLY B 160 PRO B 161 0 0.23 CISPEP 4 PRO B 268 PRO B 269 0 0.41 CISPEP 5 PRO B 315 PRO B 316 0 0.34 CRYST1 157.650 74.000 77.190 90.00 90.64 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.006343 0.000000 0.000071 0.00000 SCALE2 0.000000 0.013514 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012956 0.00000